NEWS

Quotient Sciences Announces Multimillion-Pound Investment in Drug Substance Manufacturing Facility

Read article

Events

Pharma Integrates 10th Edition

16 November 2021
Connect with Quotient Sciences at the Pharma Integrates 10th Edition Conference virtually.  We will be virtually exhibiting at the event and participating in two panel discussions during the event.  Swing by our booth and share your drug development needs with our experts and get updated on Quotient's latest capability enhancements. 
To schedule a meeting with our team at the event, email: info@quotientsciences.com

Panel Talks


Quotient's Vice President of Science & Technology, Dr Gareth Jenkins will be participating in "Are you in or out?"

Panel Summary

While pharma outsourcing is still on the rise, the pandemic has led to near-shoring or activities being brought in-house to ensure milestones could be met. Where will we make our medicines in the future?


Moderator: Mark Talford, Deputy Challenge Director, Medicines Manufacturing | Innovate UK


Other Panelists include:
Steve Barr, Vice President Business Development at SK biotek
Charlotte WIles, Chief Executive Officer at Chemtrix​
Rebecca Coutts, General Manager at PCI Pharma Services


Quotient's Executive Director of Drug Development Consulting will be participating in:
I feel the need for speed


Panel Summary:

Coronavirus vaccines were developed at unprecedented speed. With growing expectations that drugs are made more quickly, how can we accelerate timelines?


Moderator: Ian Campbell, Chief Business Officer at LifeArc


Other Panelists include:

Michael Young, Co-founder at Lindus Health
Amit Shah, Biotech Venture Capital Investor at S.R. One Ltd
Ahmend Bouzidi,  Vice President of Biotech at ProductLife Group
Tim Luker, Vice President Emerging Technology and Innovation at Eli Lilly


Event details:

We use cookies to help us to improve our site and enables us to the best possible service and customer experience. By clicking accept you are agreeing to let us share your data with select third parties for analytics and marketing purposes.